Kazuo Kasahara Selected Research

Kazuo Kasahara Research Topics

Disease

58	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 12/2002
39	Neoplasms (Cancer) 01/2022 - 02/2005
15	Lung Neoplasms (Lung Cancer) 11/2021 - 01/2004
13	Cough 10/2020 - 09/2005
11	Disease Progression 03/2021 - 09/2006
10	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2004
8	Pneumonia (Pneumonitis) 06/2021 - 10/2016
7	Adenocarcinoma of Lung 01/2021 - 09/2010
7	Asthma (Bronchial Asthma) 01/2020 - 05/2004
6	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 12/2015
6	Pleural Effusion (Pleural Effusions) 01/2020 - 03/2006
5	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 02/2013
4	COVID-19 01/2022 - 12/2020
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2019 - 06/2005
4	Adenocarcinoma 04/2015 - 06/2005
3	Inflammation (Inflammations) 10/2020 - 01/2007
3	Idiopathic Pulmonary Fibrosis 04/2019 - 10/2013
3	Carcinoma (Carcinomatosis) 01/2018 - 02/2007
2	Dentofacial Deformities 06/2022 - 03/2022
2	Small Cell Carcinoma 11/2021 - 12/2017
2	Fever (Fevers) 01/2021 - 04/2003
2	Chronic Cough 10/2020 - 10/2013
2	Thymoma (Thymic Carcinoma) 09/2020 - 01/2016
2	Dyspnea (Shortness of Breath) 01/2020 - 07/2016
2	Epilepsy (Aura) 09/2019 - 04/2018
2	Bronchiolitis Obliterans 01/2019 - 02/2017
2	Fibrosis (Cirrhosis) 11/2018 - 10/2013
2	Rheumatoid Arthritis 02/2018 - 01/2008
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2008 - 01/2008
2	Hypersensitivity (Allergy) 09/2006 - 09/2005
1	Bronchitis 10/2022
1	Obstructive Sleep Apnea 03/2022

Drug/Important Bio-Agent (IBA)

21	ErbB Receptors (EGF Receptor)IBA 11/2021 - 01/2004
18	Tyrosine Kinase InhibitorsIBA 11/2021 - 12/2005
15	Gefitinib (Iressa)FDA Link 09/2021 - 01/2004
9	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 03/2006
9	Capsaicin (Zostrix)FDA Link 10/2020 - 09/2005
8	NivolumabIBA 04/2022 - 10/2016
8	Pharmaceutical PreparationsIBA 09/2021 - 12/2005
7	pembrolizumabIBA 01/2022 - 03/2019
7	PlatinumIBA 08/2021 - 09/2006
7	Methacholine Chloride (Methacholine)FDA Link 10/2020 - 09/2005
7	Carboplatin (JM8)FDA LinkGeneric 09/2020 - 12/2002
5	Pemetrexed (MTA)FDA Link 08/2021 - 06/2014
5	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 02/2007
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 10/2013
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 02/2012
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2018
4	osimertinibIBA 11/2019 - 01/2018
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016 - 09/2012
4	Gemcitabine FDA Link 12/2009 - 09/2006
3	B7-H1 AntigenIBA 01/2022 - 03/2019
3	Biomarkers (Surrogate Marker)IBA 06/2021 - 09/2010
3	Dinoprostone (PGE2)FDA Link 10/2020 - 01/2018
3	CytokinesIBA 10/2020 - 02/2005
3	Bronchodilator Agents (Bronchodilators)IBA 10/2020 - 05/2004
3	130-nm albumin-bound paclitaxelIBA 09/2020 - 07/2013
3	Immunoglobulin G (IgG)IBA 11/2018 - 09/2005
3	Docetaxel (Taxotere)FDA Link 01/2016 - 12/2002
3	AntigensIBA 10/2013 - 09/2005
3	Vinorelbine (Navelbine)FDA LinkGeneric 09/2007 - 06/2007
2	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 03/2021 - 06/2004
2	LigandsIBA 01/2021 - 03/2019
2	Cell-Free Nucleic AcidsIBA 01/2021 - 03/2018
2	ProstaglandinsIBA 10/2020 - 06/2005
2	LipidsIBA 04/2020 - 01/2018
2	Epoprostenol ReceptorsIBA 04/2020 - 12/2018
2	Anaplastic Lymphoma KinaseIBA 01/2020 - 04/2013
2	Bevacizumab (Avastin)FDA Link 10/2019 - 12/2011
2	Immunoglobulin E (IgE)IBA 04/2019 - 09/2005
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2018 - 12/2014
2	fluticasone furoate FDA Link 01/2018 - 12/2015
2	AntibodiesIBA 08/2016 - 02/2005
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2016 - 09/2010
2	SteroidsIBA 01/2008 - 04/2003
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2006 - 03/2006
1	Axitinib (AG 013736)IBA 10/2022
1	IpilimumabIBA 04/2022
1	Oxygen (Dioxygen)IBA 03/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2022
1	Denosumab FDA Link 01/2022
1	Therapeutic UsesIBA 01/2022
1	ParaffinIBA 11/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2021
1	Growth Factor ReceptorsIBA 11/2021

Therapy/Procedure

34	Therapeutics 11/2021 - 09/2007
28	Drug Therapy (Chemotherapy) 04/2022 - 04/2003
5	Combination Drug Therapy (Combination Chemotherapy) 08/2008 - 12/2002
4	X-Ray Film 04/2015 - 03/2006
3	Traditional Medicine (Folk Remedies) 07/2018 - 07/2013
2	Radiotherapy 10/2022 - 05/2012
2	Airway Management 03/2022 - 05/2012
2	Aftercare (After-Treatment) 10/2020 - 06/2007
2	Chemoradiotherapy 01/2020 - 05/2012
1	Orthognathic Surgery 06/2022
1	Osteotomy 03/2022
1	Conservative Treatment 01/2022
1	Molecular Targeted Therapy 11/2021